An update on vitamin D and human immunity

In the last 5 years, there has been a remarkable change in our understanding of the health benefits of vitamin D. The classical actions of vitamin D as a determinant of mineral metabolism and rachitic bone disease have been expanded to include a broader role in skeletal homoeostasis and prevalent bone disorders such as osteoporosis. However, it is the nonskeletal function of vitamin D that has attracted most attention. Although pluripotent responses to vitamin D have been recognized for many years, our new perspective on nonclassical vitamin D function stems from two more recent concepts. The first is that impaired, vitamin D status is common to many populations across the globe. This has prompted studies to explore the health impact of suboptimal circulating levels of vitamin D, with association studies linking vitamin D ‘insufficiency’ to several chronic health problems including autoimmune and cardiovascular disease, hypertension and common cancers. In support of a broader role for vitamin D in human health, studies in vitro and using animal models have highlighted immunomodulatory and anticancer effects of vitamin D that appear to depend on localized activation of vitamin D. The conclusion from these reports is that many nonclassical actions of vitamin D are independent of conventional vitamin D endocrinology and are therefore more sensitive to variations in vitamin D status. The current review summarizes these developments, with specific reference to the newly identified effects of vitamin D on the immune system, but also highlights the challenges in translating these observations to clinical practice.

[1]  A. Konstantinos Vitamin D and tuberculosis , 2014, The Medical journal of Australia.

[2]  J. Powell,et al.  Vitamin D and cardiovascular disease. , 2014, Circulation research.

[3]  D. Barceló,et al.  Liquid chromatography–tandem mass spectrometry , 2013, Analytical and Bioanalytical Chemistry.

[4]  J. Stockman Common genetic determinants of vitamin D insufficiency: a genome-wide association study , 2012 .

[5]  D. Eyles,et al.  Vitamin D and the brain. , 2011, Best practice & research. Clinical endocrinology & metabolism.

[6]  Sneha S. Joshi,et al.  1,25-Dihydroxyvitamin D3 Ameliorates Th17 Autoimmunity via Transcriptional Modulation of Interleukin-17A , 2011, Molecular and Cellular Biology.

[7]  A. Rudensky,et al.  Regulatory T cells and Foxp3 , 2011, Immunological reviews.

[8]  C. Wagner,et al.  The vitamin D requirement during human lactation: the facts and IOM's ‘utter’ failure , 2011, Public Health Nutrition.

[9]  W. Grant The Institute of Medicine did not find the vitamin D–cancer link because it ignored UV-B dose studies , 2011, Public Health Nutrition.

[10]  I. Bhan,et al.  Vitamin D–Binding Protein Modifies the Vitamin D–Bone Mineral Density Relationship , 2011, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[11]  R. Heaney,et al.  Why the IOM recommendations for vitamin D are deficient , 2011, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[12]  J. Geleijnse Vitamin D and the prevention of hypertension and cardiovascular diseases: a review of the current evidence. , 2011, American journal of hypertension.

[13]  A. Avenell,et al.  Evidence‐based policy on dietary calcium and vitamin D , 2011, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[14]  R. Recker,et al.  Vitamin D(3) is more potent than vitamin D(2) in humans. , 2011, The Journal of clinical endocrinology and metabolism.

[15]  A. Slomski IOM endorses vitamin D, calcium only for bone health, dispels deficiency claims. , 2011, JAMA.

[16]  R. Wilkinson,et al.  High-dose vitamin D3 during intensive-phase antimicrobial treatment of pulmonary tuberculosis: a double-blind randomised controlled trial , 2011, The Lancet.

[17]  R. Stockley,et al.  Vitamin D-binding protein contributes to COPD by activation of alveolar macrophages , 2011, Thorax.

[18]  W. Grant Is the Institute of Medicine Report on Calcium and Vitamin D Good Science? , 2011, Biological research for nursing.

[19]  D. Feldman,et al.  Mechanisms of the anti-cancer and anti-inflammatory actions of vitamin D. , 2011, Annual review of pharmacology and toxicology.

[20]  JoAnn E. Manson,et al.  The 2011 Report on Dietary Reference Intakes for Calcium and Vitamin D from the Institute of Medicine: What Clinicians Need to Know , 2010, The Journal of clinical endocrinology and metabolism.

[21]  R. Heaney 25-Hydroxyvitamin D and calcium absorption. , 2011, The American journal of clinical nutrition.

[22]  S. Bae,et al.  Associations between vitamin D receptor polymorphisms and susceptibility to rheumatoid arthritis and systemic lupus erythematosus: a meta-analysis , 2011, Molecular Biology Reports.

[23]  B. Musellim,et al.  The association between BsmI variant of vitamin D receptor gene and susceptibility to tuberculosis , 2011, Molecular Biology Reports.

[24]  J. Adams,et al.  T-cell cytokines differentially control human monocyte antimicrobial responses by regulating vitamin D metabolism , 2010, Proceedings of the National Academy of Sciences.

[25]  Jonathan Himmelfarb,et al.  Current Opinion in Nephrology and Hypertension , 2010 .

[26]  M. Vogeser Quantification of circulating 25-hydroxyvitamin D by liquid chromatography–tandem mass spectrometry , 2010, The Journal of Steroid Biochemistry and Molecular Biology.

[27]  T. Olsson,et al.  Confirmation of association between multiple sclerosis and CYP27B1 , 2010, European Journal of Human Genetics.

[28]  M. Wheeler,et al.  Proficiency testing of 25-Hydroxyvitamin D (25-OHD) assays , 2010, The Journal of Steroid Biochemistry and Molecular Biology.

[29]  R. Wilkinson,et al.  Vitamin D-binding protein directs monocyte responses to 25-hydroxy- and 1,25-dihydroxyvitamin D. , 2010, The Journal of clinical endocrinology and metabolism.

[30]  R. Hayes,et al.  Circulating 25-Hydroxyvitamin D and Risk of Pancreatic Cancer , 2010, American journal of epidemiology.

[31]  J. T. Afshari,et al.  Lack of association of vitamin D receptor gene BsmI polymorphisms in patients with systemic lupus erythematosus , 2010, Rheumatology International.

[32]  Jian-Huang Wu,et al.  Association between FokI polymorphism in vitamin D receptor gene and susceptibility to spinal tuberculosis in Chinese Han population. , 2010, Archives of medical research.

[33]  L. Gao,et al.  Vitamin D receptor genetic polymorphisms and tuberculosis: updated systematic review and meta-analysis. , 2010, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[34]  M. Mura,et al.  1,25-Dihydroxyvitamin D3 and IL-2 Combine to Inhibit T Cell Production of Inflammatory Cytokines and Promote Development of Regulatory T Cells Expressing CTLA-4 and FoxP31 , 2009, The Journal of Immunology.

[35]  P. Glendenning,et al.  Serum 25-hydroxyvitamin D levels in vitamin D-insufficient hip fracture patients after supplementation with ergocalciferol and cholecalciferol. , 2009, Bone.

[36]  G. Cheng,et al.  Divergence of macrophage phagocytic and antimicrobial programs in leprosy. , 2009, Cell host & microbe.

[37]  R. Spíšek,et al.  Paricalcitol (19-nor-1,25-dihydroxyvitamin D2) and calcitriol (1,25-dihydroxyvitamin D3) exert potent immunomodulatory effects on dendritic cells and inhibit induction of antigen-specific T cells. , 2009, Clinical immunology.

[38]  S. Anderson,et al.  Association between Gc genotype and susceptibility to TB is dependent on vitamin D status , 2009, European Respiratory Journal.

[39]  Justin A. Spanier,et al.  Estrogen Controls Vitamin D3-Mediated Resistance to Experimental Autoimmune Encephalomyelitis by Controlling Vitamin D3 Metabolism and Receptor Expression1 , 2009, The Journal of Immunology.

[40]  P. Menheere,et al.  Association Study on Two Vitamin D Receptor Gene Polymorphisms and Vitamin D Metabolites in Multiple Sclerosis , 2009, Annals of the New York Academy of Sciences.

[41]  Kerry Naunton,et al.  Peripheral blood regulatory T cell measurements correlate with serum vitamin D levels in patients with multiple sclerosis , 2009, Journal of Neuroimmunology.

[42]  P. Menheere,et al.  Vitamin D Status Is Positively Correlated with Regulatory T Cell Function in Patients with Multiple Sclerosis , 2009, PloS one.

[43]  BD Beretich,et al.  Explaining multiple sclerosis prevalence by ultraviolet exposure: a geospatial analysis , 2009, Multiple sclerosis.

[44]  G. Cheng,et al.  Convergence of IL-1β and VDR Activation Pathways in Human TLR2/1-Induced Antimicrobial Responses , 2009, PloS one.

[45]  M. Sodemann,et al.  Vitamin D as supplementary treatment for tuberculosis: a double-blind, randomized, placebo-controlled trial. , 2009, American journal of respiratory and critical care medicine.

[46]  G. Martin,et al.  Journal of Translational Medicine BioMed Central Review , 2008 .

[47]  L. Adorini,et al.  Calcitriol Suppresses Antiretinal Autoimmunity through Inhibitory Effects on the Th17 Effector Response 1 , 2009, The Journal of Immunology.

[48]  R. Daynes,et al.  TLR-Induced Local Metabolism of Vitamin D3 Plays an Important Role in the Diversification of Adaptive Immune Responses1 , 2009, The Journal of Immunology.

[49]  A. Gombart,et al.  Vitamin D-Directed Rheostatic Regulation of Monocyte Antibacterial Responses1 , 2009, The Journal of Immunology.

[50]  D. Rao,et al.  Determinants of 25-hydroxyvitamin D levels in African-American and Caucasian male veterans , 2009, Osteoporosis International.

[51]  L. Nguyen,et al.  Vitamin D Induces Innate Antibacterial Responses in Human Trophoblasts via an Intracrine Pathway1 , 2009, Biology of reproduction.

[52]  C. Camargo,et al.  Low plasma level of cathelicidin antimicrobial peptide (hCAP18) predicts increased infectious disease mortality in patients undergoing hemodialysis. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[53]  N. Tandon,et al.  Prevalence of vitamin D deficiency and its relationship with thyroid autoimmunity in Asian Indians: a community-based survey , 2009, British Journal of Nutrition.

[54]  M. Holick,et al.  Vitamin D status: measurement, interpretation, and clinical application. , 2009, Annals of epidemiology.

[55]  G. Carter,et al.  Use of a common standard improves the performance of liquid chromatography-tandem mass spectrometry methods for serum 25-hydroxyvitamin-D , 2009, Annals of clinical biochemistry.

[56]  1,25-Dihydroxyvitamin D3 and IL-2 Combine to Inhibit T Cell Production of Inflammatory Cytokines and Promote Development of Regulatory T Cells Expressing CTLA-4 and FoxP3 , 2009 .

[57]  J. Adams,et al.  IL-15 Links TLR2/1-Induced Macrophage Differentiation to the Vitamin D-Dependent Antimicrobial Pathway , 2008, The Journal of Immunology.

[58]  S. Anderson,et al.  VITAMIN D DEFICIENCY AND INSUFFICIENCY IN CHILDREN WITH TUBERCULOSIS , 2008, The Pediatric infectious disease journal.

[59]  M. Haussler,et al.  Vitamin D receptor: molecular signaling and actions of nutritional ligands in disease prevention. , 2008, Nutrition reviews.

[60]  D. Kamen,et al.  Vitamin D in systemic lupus erythematosus , 2008, Current opinion in rheumatology.

[61]  A. Scillitani,et al.  Short and long-term variations in serum calciotropic hormones after a single very large dose of ergocalciferol (vitamin D2) or cholecalciferol (vitamin D3) in the elderly. , 2008, The Journal of clinical endocrinology and metabolism.

[62]  Andreas Radbruch,et al.  1,25‐dihydroxyvitamin D3 promotes IL‐10 production in human B cells , 2008, European journal of immunology.

[63]  L. Adorini,et al.  Control of autoimmune diseases by the vitamin D endocrine system , 2008, Nature Clinical Practice Rheumatology.

[64]  O. Yoshie,et al.  1,25-Dihydroxyvitamin D3 Induces CCR10 Expression in Terminally Differentiating Human B Cells1 , 2008, The Journal of Immunology.

[65]  M. Holick,et al.  Vitamin D2 is as effective as vitamin D3 in maintaining circulating concentrations of 25-hydroxyvitamin D. , 2008, The Journal of clinical endocrinology and metabolism.

[66]  A. Clarke,et al.  Low serum vitamin D levels and tuberculosis: a systematic review and meta-analysis. , 2008, International journal of epidemiology.

[67]  P. Dhawan,et al.  Induction of cathelicidin in normal and CF bronchial epithelial cells by 1,25-dihydroxyvitamin D(3). , 2007, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[68]  J. Todd,et al.  Association of the Vitamin D Metabolism Gene CYP27B1 With Type 1 Diabetes , 2007, Diabetes.

[69]  D. Trump,et al.  Vitamin D signalling pathways in cancer: potential for anticancer therapeutics , 2007, Nature Reviews Cancer.

[70]  P. Lipsky,et al.  Modulatory Effects of 1,25-Dihydroxyvitamin D3 on Human B Cell Differentiation , 2007, The Journal of Immunology.

[71]  Robert J Wilkinson,et al.  A single dose of vitamin D enhances immunity to mycobacteria. , 2007, American journal of respiratory and critical care medicine.

[72]  J. Söderlund,et al.  The antimicrobial peptide LL-37 inhibits HIV-1 replication. , 2007, Current HIV research.

[73]  H. Argani,et al.  Calcitriol started in the donor, expands the population of CD4+CD25+ T cells in renal transplant recipients. , 2007, Transplantation proceedings.

[74]  R. Wilkinson,et al.  Vitamin D in the treatment of pulmonary tuberculosis , 2007, The Journal of Steroid Biochemistry and Molecular Biology.

[75]  N. Range,et al.  Influence of candidate susceptibility genes on tuberculosis in a high endemic region. , 2007, Molecular immunology.

[76]  Junliang Pan,et al.  DCs metabolize sunlight-induced vitamin D3 to 'program' T cell attraction to the epidermal chemokine CCL27 , 2007, Nature Immunology.

[77]  Y. Helfrich,et al.  Injury enhances TLR2 function and antimicrobial peptide expression through a vitamin D-dependent mechanism. , 2007, The Journal of clinical investigation.

[78]  A. Ascherio,et al.  Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. , 2006, JAMA.

[79]  C. Doglioni,et al.  Treatment of Experimental Autoimmune Prostatitis in Nonobese Diabetic Mice by the Vitamin D Receptor Agonist Elocalcitol1 , 2006, The Journal of Immunology.

[80]  L. Nguyen,et al.  Effects of 25-Hydroxyvitamin D3 and 1,25-Dihydroxyvitamin D3 on Cytokine Production by Human Decidual Cells1 , 2006, Biology of reproduction.

[81]  S. Romagnani Regulation of the T cell response , 2006, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[82]  L. Nyström,et al.  Lower levels of plasma 25-hydroxyvitamin D among young adults at diagnosis of autoimmune type 1 diabetes compared with control subjects: results from the nationwide Diabetes Incidence Study in Sweden (DISS) , 2006, Diabetologia.

[83]  K. Badenhoop,et al.  Protection From Type 1 Diabetes by Vitamin D Receptor Haplotypes , 2006, Annals of the New York Academy of Sciences.

[84]  S. Madronich,et al.  Epidemic influenza and vitamin D , 2006, Epidemiology and Infection.

[85]  J. Aloia,et al.  Optimal vitamin D status and serum parathyroid hormone concentrations in African American women. , 2006, The American journal of clinical nutrition.

[86]  M. Cantorna,et al.  Vitamin D and its role in immunology: multiple sclerosis, and inflammatory bowel disease. , 2006, Progress in biophysics and molecular biology.

[87]  Maureen L. Coleman,et al.  Genomic Islands and the Ecology and Evolution of Prochlorococcus , 2006, Science.

[88]  C. Rumende,et al.  The effect of vitamin D as supplementary treatment in patients with moderately advanced pulmonary tuberculous lesion. , 2006, Acta medica Indonesiana.

[89]  G. Sigurdsson,et al.  Relationship between serum parathyroid hormone levels, vitamin D sufficiency, and calcium intake. , 2005, JAMA.

[90]  S. Lewis,et al.  Meta-analysis of vitamin D receptor polymorphisms and pulmonary tuberculosis risk. , 2005, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[91]  K. Spach,et al.  Vitamin D3 Confers Protection from Autoimmune Encephalomyelitis Only in Female Mice1 , 2005, The Journal of Immunology.

[92]  S. Nagpal,et al.  Noncalcemic actions of vitamin D receptor ligands. , 2005, Endocrine reviews.

[93]  H. Koeffler,et al.  Human cathelicidin antimicrobial peptide (CAMP) gene is a direct target of the vitamin D receptor and is strongly up‐regulated in myeloid cells by 1,25‐dihydroxyvitamin D3 , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[94]  H. Wulf,et al.  How Finsen's light cured lupus vulgaris , 2005, Photodermatology, photoimmunology & photomedicine.

[95]  R. Wilkinson,et al.  Prevalence and associations of vitamin D deficiency in foreign-born persons with tuberculosis in London. , 2005, The Journal of infection.

[96]  S. Pearce,et al.  A haplotype of the CYP27B1 promoter is associated with autoimmune Addison's disease but not with Graves' disease in a UK population. , 2005, Journal of molecular endocrinology.

[97]  S. Harris Vitamin D in type 1 diabetes prevention. , 2005, The Journal of nutrition.

[98]  R. Lea,et al.  VARIATION IN THE VITAMIN D RECEPTOR GENE IS ASSOCIATED WITH MULTIPLE SCLEROSIS IN AN AUSTRALIAN POPULATION , 2005, Journal of neurogenetics.

[99]  S. Akira,et al.  Toll-like receptors in innate immunity. , 2004, International immunology.

[100]  P. Vestergaard,et al.  Plasma concentrations of 25-Hydroxy-Vitamin D and 1,25-Dihydroxy-Vitamin D are Related to the Phenotype of Gc (Vitamin D-Binding Protein): A Cross-sectional Study on 595 Early Postmenopausal Women , 2005, Calcified Tissue International.

[101]  John H. White,et al.  Cutting Edge: 1,25-Dihydroxyvitamin D3 Is a Direct Inducer of Antimicrobial Peptide Gene Expression , 2004, The Journal of Immunology.

[102]  A. Uitterlinden,et al.  Genetics and biology of vitamin D receptor polymorphisms. , 2004, Gene.

[103]  Tsuyoshi Kayo,et al.  Gene expression analysis suggests that 1,25-dihydroxyvitamin D3 reverses experimental autoimmune encephalomyelitis by stimulating inflammatory cell apoptosis. , 2004, Physiological genomics.

[104]  J. Constans,et al.  Affinity differences for vitamin D metabolites associated with the genetic isoforms of the human serum carrier protein (DBP) , 1993, Human Genetics.

[105]  R. Grad Cod and the consumptive: a brief history of cod-liver oil in the treatment of pulmonary tuberculosis. , 2004, Pharmacy in history.

[106]  M. Uskoković,et al.  Tolerogenic dendritic cells induced by vitamin D receptor ligands enhance regulatory T cells inhibiting allograft rejection and autoimmune diseases. , 2004, Journal of cellular biochemistry.

[107]  R. Andreesen,et al.  Regulation of 25-hydroxyvitamin D3-1α-hydroxylase and production of 1α,25-dihydroxyvitamin D3 by human dendritic cells , 2003 .

[108]  Aristides G. Eliopoulos,et al.  Differential Regulation of Vitamin D Receptor and Its Ligand in Human Monocyte-Derived Dendritic Cells1 , 2003, The Journal of Immunology.

[109]  Cecilia A. Hale,et al.  Calcium Absorption Varies within the Reference Range for Serum 25-Hydroxyvitamin D , 2003, Journal of the American College of Nutrition.

[110]  R. Andreesen,et al.  Regulation of 25-hydroxyvitamin D3-1 alpha-hydroxylase and production of 1 alpha,25-dihydroxyvitamin D3 by human dendritic cells. , 2003, Blood.

[111]  David F. Richards,et al.  In Vitro Generation of Interleukin 10–producing Regulatory CD4+ T Cells Is Induced by Immunosuppressive Drugs and Inhibited by T Helper Type 1 (Th1)– and Th2-inducing Cytokines , 2002, The Journal of experimental medicine.

[112]  H. Ohmori,et al.  HUMAN NEUTROPHILS EXPRESS MESSENGER RNA OF VITAMIN D RECEPTOR AND RESPOND TO 1α,25-DIHYDROXYVITAMIN D3 , 2002, Immunopharmacology and immunotoxicology.

[113]  M. Tremblay,et al.  Targeted ablation of the 25-hydroxyvitamin D 1α-hydroxylase enzyme: Evidence for skeletal, reproductive, and immune dysfunction , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[114]  R. Kumar,et al.  Dendritic cell modulation by 1α,25 dihydroxyvitamin D3 and its analogs: A vitamin D receptor-dependent pathway that promotes a persistent state of immaturity in vitro and in vivo , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[115]  P. Vestergaard,et al.  Mean serum concentration of vitamin D-binding protein (Gc globulin) is related to the Gc phenotype in women. , 2001, Clinical chemistry.

[116]  M. Taniyama,et al.  Vitamin D receptor gene polymorphism is associated with Graves' disease in the Japanese population. , 2000, The Journal of clinical endocrinology and metabolism.

[117]  L. Adorini,et al.  1α,25-Dihydroxyvitamin D3 Inhibits Differentiation, Maturation, Activation, and Survival of Dendritic Cells Leading to Impaired Alloreactive T Cell Activation , 2000, The Journal of Immunology.

[118]  R. Wilkinson,et al.  Influence of vitamin D deficiency and vitamin D receptor polymorphisms on tuberculosis among Gujarati Asians in west London: a case-control study , 2000, The Lancet.

[119]  J. Cowland,et al.  An ELISA for hCAP-18, the cathelicidin present in human neutrophils and plasma. , 1997, Journal of immunological methods.

[120]  Y. Taketani,et al.  A Vitamin D Receptor Gene Polymorphism in the Translation Initiation Codon: Effect on Protein Activity and Relation to Bone Mineral Density in Japanese Women , 1997, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[121]  P. Galan,et al.  Prevalence of Vitamin D Insufficiency in an Adult Normal Population , 1997, Osteoporosis International.

[122]  Kenneth M. Murphy,et al.  Functional diversity of helper T lymphocytes , 1996, Nature.

[123]  H. DeLuca,et al.  1,25-Dihydroxyvitamin D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[124]  H. Spiegelberg,et al.  Immunosuppressive actions of 1,25-dihydroxyvitamin D3: preferential inhibition of Th1 functions. , 1995, The Journal of nutrition.

[125]  N. Yamamoto,et al.  Vitamin D3 binding protein (group-specific component) is a precursor for the macrophage-activating signal factor from lysophosphatidylcholine-treated lymphocytes. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[126]  S. A. Westwood,et al.  The phenotypic frequencies of group specific component and alpha-2-HS-glycoprotein in three ethnic groups. The use of these proteins as racial markers in forensic biology. , 1987, Forensic science international.

[127]  D. Katz,et al.  Dendritic cells from human tissues express receptors for the immunoregulatory vitamin D3 metabolite, dihydroxycholecalciferol. , 1987, Immunology.

[128]  G. Rook,et al.  Vitamin D3, gamma interferon, and control of proliferation of Mycobacterium tuberculosis by human monocytes. , 1986, Immunology.

[129]  J. Adams,et al.  1,25-Dihydroxyvitamin D3 suppresses human T helper/inducer lymphocyte activity in vitro. , 1985, Journal of immunology.

[130]  H. Koeffler,et al.  gamma-Interferon stimulates production of 1,25-dihydroxyvitamin D3 by normal human macrophages. , 1985, Biochemical and biophysical research communications.

[131]  J. Adams,et al.  1 alpha,25-dihydroxyvitamin D3 suppresses proliferation and immunoglobulin production by normal human peripheral blood mononuclear cells. , 1984, The Journal of clinical investigation.

[132]  S. Manolagas,et al.  1,25-dihydroxyvitamin D3 receptors in human leukocytes. , 1983, Science.

[133]  T. Oppé,et al.  Vitamin D deficiency. , 1979, British medical journal.

[134]  G. Herrera Vitamin D in massive doses as an adjuvant to the sulfones in the treatment of tuberculoid leprosy. , 1949, International journal of Leprosy.

[135]  H. Chaglassian Calciferol Treatment of Leprosy1: Preliminary Report of Two Cases , 1948 .

[136]  H. Chaglassian Calciferol treatment of leprosy; preliminary report of two cases. , 1948, The Journal of investigative dermatology.